| ADP | Adenosine diphosphate |
| AGES | Advanced glycation end products |
| ALA | Alpha-lipoic acid |
| ASIC | Acid-sensing ion channels |
| ATP | Adenosine triphosphate |
| BDNF | Brain-derived neurotrophic factor |
| CPC | Cooperative patent classification |
| DHLA | Dihydrolipoic acid |
| DRG | Dorsal root ganglia |
| DSPN | Diabetic sensorimotor polyneuropathy |
| GNP | Gold nanoparticles |
| IL-1β | Interleukin 1 beta |
| IPC | International patent classification |
| MPTP | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| MTT | 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide |
| NADPH | Nicotinamide adenine dinucleotide phosphate |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| Nox | Nicotinamide adenine dinucleotide phosphate oxidases |
| NP | Neuropathic pain |
| PPAR | Poly (ADP-ribose) polymerase |
| RNS | Reactive nitrogen species |
| ROS | Reactive oxygen species |
| SOD | Superoxide dismutase |
| STZ | Streptozotocin |
| TNF-α | Tumor necrosis factor alpha |
| TrkB | Tropomyosin receptor kinase B |
| TRPA1 | Transient receptor potential ankyrin subtype 1 |
| TRPV1 | Transient receptor potential vanilloid subtype 1 |